The continuing burden of Rh disease 50 years after the introduction of anti-Rh(D) immunoglobin prophylaxis: call to action

Autor:	Gerard H.A. Visser, Gian Carlo Di Renzo, Steven L. Spitalnik, Diogo Ayres-de-Campos, Maria Fernanda Escobar, Eytan Barnea, P.K. Shah, Anwar Nasser, Luc de Bernis, Luming Sun, Wanda Kay Nicholson, Isabel Lloyd, Salimah Walani, Gerhard Theron, William Stones
Rok vydání:	2019
Předmět:	medicine.medical_specialty fetal anemia Internationality hyperbilirubinemia Rho(D) Immune Globulin Disease isoimmunization Rh Isoimmunization blood groups Health Services Accessibility 03 medical and health sciences 0302 clinical medicine Fetal anemia prevention Pregnancy medicine alloimmunization hemolysis hemolytic disease of the fetus and newborn Rh disease Female Humans Immunologic Factors Prenatal Care Rh-Hr Blood-Group System 030212 general & internal medicine Intensive care medicine 030219 obstetrics & reproductive medicine biology business.industry Obstetrics and Gynecology Call to action biology.protein Severe morbidity Antibody business Perinatal Deaths
Zdroj:	American journal of obstetrics and gynecology. 221(3)
ISSN:	1097-6868
Popis:	Severe morbidity and death because of Rh disease have only been reduced by approximately 50% globally during the last 50 years, despite the advent of anti-Rh(D) immunoglobin prophylaxis, which has resulted in >160,000 perinatal deaths and 100,000 disabilities annually. This apparent failure to take appropriate preventive measures is of great concern. Thus, there is a great need to do much better. We wish to draw attention to the unnecessary continuing burden of Rh disease, to discuss some of the reasons for this failure, and to provide suggestions for a better way forward.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c411b1eab870f3761360e20263eb2c82 https://pubmed.ncbi.nlm.nih.gov/31121145 Zobrazit plný text záznamu Full Text from ScienceDirect